No Man

Sign in

Join Free
Post RFQ

Selinexor

TypeName: Business Offer

Category:

Offer Date:2019/07/13

Country: United States

Summary: Selinexor is a potent and selective inhibitor of chromosome region maintenance 1 protein/exportin 1 (CRM1/XPO1). Selinexor was studied to show in vivo anti-leukaemic efficacy against T-ALL and acute myeloid leukaemia (AML) cells.https://www.bocsci.com/selinexor-cas-1393477-72-9-item-463408.html

Description:

OfferId: 4887

Name:Alex Brown

Telphone:

Email:[email protected]